Similar articles

• Open prostatectomy versus transurethral resection of the prostate, where are we standing in the new era? A randomized controlled trial.

  Simforoosh N, Abdi H, Kashi AH, Zare S, Tabibi A, Danesh A, Basiri A, Ziaee SA. Simforoosh N, et al. Urol J. 2010 Fall;7(4):262-9. Urol J. 2010. PMID: 21170857 Clinical Trial.
• A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.

  Stovsky MD, Griffiths RI, Duff SB. Stovsky MD, et al. J Urol. 2006 Oct;176(4 Pt 1):1500-6. doi: 10.1016/j.juro.2006.06.064. J Urol. 2006. PMID: 16952668
• Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.

  Rosario DJ, Phillips JT, Chapple CR. Rosario DJ, et al. J Urol. 2007 Mar;177(3):1047-51; discussion 1051. doi: 10.1016/j.juro.2006.10.042. J Urol. 2007. PMID: 17296409
• [Benign prostatic hyperplasia: surgical treatment].

  Seitz M, Gratzke C, Schlenker B, Karl A, Stanislaus P, Walther S, Stief CG, Reich O. Seitz M, et al. MMW Fortschr Med. 2007 Aug 16;149(33-34):34-6. MMW Fortschr Med. 2007. PMID: 17912864 Review. German.
• Economic Value of the Transurethral Resection in Saline System for Treatment of Benign Prostatic Hyperplasia in England and Wales: Systematic Review, Meta-analysis, and Cost-Consequence Model.

  Treharne C, Crowe L, Booth D, Ihara Z. Treharne C, et al. Eur Urol Focus. 2018 Mar;4(2):270-279. doi: 10.1016/j.euf.2016.03.002. Epub 2016 Mar 23. Eur Urol Focus. 2018. PMID: 28753756